Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Crossing the rubicon in lung adenocarcinoma: the conundrum of EGFR tyrosine kinase mutations.

Future oncology (London, England) - 1 Jun 2005

Rosell Rafael, Felip Enriqueta, Reguart Noemí, Moran Teresa

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Antineoplastic Agents
Share to ErbB Receptors
Share to EGFR gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Mutation

Source

Identifiers

PMID: 16556005
DOI: 10.1517/14796694.1.3.319

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Crossing the rubicon in lung adenocarcinoma: the conundrum of EGFR tyrosine kinase mutations.PMID 16556005Read ↗

Cancer: Closing the door on KRAS-mutant lung cancer.Semantic proximity Read ↗

Deregulated EGFR signaling during lung cancer progression: mutations, amplicons, and autocrine loops.Semantic proximity Read ↗

Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond.Semantic proximity Read ↗

EGFR testing in lung cancer is ready for prime time.Semantic proximity Read ↗

EGFR mutations and molecularly targeted therapy: a new era in the treatment of lung cancer.Semantic proximity Read ↗

Lung cancer: Functional insights into cancer mutations-eVIP approach.Semantic proximity Read ↗

Emerging gene mutation targets in lung cancer.Semantic proximity Read ↗

A Novel EGFR Germline Mutation in Lung Adenocarcinoma: Case Report and Literature ReviewSemantic proximity Read ↗

EGFR signaling pathway as therapeutic target in human cancers.Semantic proximity Read ↗

Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline MutationsSemantic proximity Read ↗

Germline mutations in lung cancer and personalized medicine.Semantic proximity Read ↗

Lung cancer in 'never-smokers': beyond EGFR mutations and EGFR-TK inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.